CSI uses 10-color flow cytometry – a sophisticated method for providing diagnosis, prognosis, and monitoring of malignancies with a relatively small sample size. With our skilled flow technologists and hematopathologists, we are quickly able to identify emerging abnormalities and perform rare event analysis of patient-specific aberrant immunophenotypes.

As the front line for cancer testing and a key factor in determining downstream testing, CSI Laboratories’ platform is one of the most advanced flow cytometry testing services on the market today. CSI flow provides:

  • An advanced 10-color platform yielding more information per tube
  • Full characterization of low cellularity samples
  • A proprietary panel design for reduced interference of co-expression
  • Viability dye in all tubes to exclude non-viable events for improved analysis
  • Kappa/Lambda combined in a single tube for B-cell abnormalities
  • Client re-gating with FCS Express Reader
  • Expert hematopathology consult services for difficult flow cytometry cases
  • Antibody panel formulations personalized for each case to maximize accurate diagnoses
  • Paroxysmal Nocturnal Hemoglobinuria (PNH) testing using high sensitivity FLAER-based analysis to diagnose and monitor PNH clones for treatment using eculizumab therapy

Talk to your sales representative about this and other advantages CSI can provide to your organization.

Comprehensive PanelsReflex Panels
Leukemia/Lymphoma (Bone Marrow/Peripheral Blood)AML-M0Mast Cell MM
Leukemia/Lymphoma (Tissue and Fluid)AML-M6/M7PNH RBC
LymphomaBAL 4/8T+B Combo
High-Sensitivity PNHB-ALLT-ALL
BM5T-Cell (α/β;γ/δ)
FCLZAP70
HCL